BDTX logo

Black Diamond Therapeutics, Inc. Common Stock


BDTX: Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-189 and BDTX-1535.


Show BDTX Financials

Consumer Interest
SEC Filings

Recent trades of BDTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BDTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Tyrosine kinase inhibitor compositions, methods of making and methods of use Jun. 15, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BDTX in WallStreetBets Daily Discussion


Recent insights relating to BDTX

CNBC Recommendations

Recent picks made for BDTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BDTX

Corporate Flights

Flights by private jets registered to BDTX